Covington Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Covington Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$170K	Buy	1,450 +675	+87%	+$83.8K	0.01%	377
2022 Q2	$91K	Buy	775 +700	+933%	+$83.1K	﹤0.01%	473
2022 Q1	$10K	Hold	75	–	–	﹤0.01%	824
2021 Q4	$11K	Hold	75	–	–	﹤0.01%	770
2021 Q3	$12K	Buy	+75	New	+$12.6K	﹤0.01%	788
2021 Q2	–	Sell	-200	Closed	-$30K	–	963
2021 Q1	$30K	Sell	200 -170	-46%	-$27K	﹤0.01%	542
2020 Q4	$56K	Buy	370 +170	+85%	+$24.3K	﹤0.01%	449
2020 Q3	$27K	Hold	200	–	–	﹤0.01%	506
2020 Q2	$27K	Buy	+200	New	+$25.5K	﹤0.01%	509
2019 Q1	–	Sell	-225	Closed	-$22K	–	737
2018 Q4	$22K	Hold	225	–	–	﹤0.01%	530
2018 Q3	$27K	Hold	225	–	–	﹤0.01%	494
2018 Q2	$25K	Hold	225	–	–	﹤0.01%	519
2018 Q1	$24K	Hold	225	–	–	﹤0.01%	527
2017 Q4	$24K	Hold	225	–	–	﹤0.01%	560
2017 Q3	$25K	Buy	+225	New	+$24K	﹤0.01%	520
2016 Q1	–	Sell	-1,995	Closed	-$225K	–	238
2015 Q4	$225K	Sell	1,995 -75	-4%	-$8.14K	0.02%	225
2015 Q3	$209K	Sell	2,070 -225	-10%	-$27K	0.02%	229
2015 Q2	$282K	Hold	2,295	–	–	0.03%	226
2015 Q1	$263K	Hold	2,295	–	–	0.03%	212
2014 Q4	$232K	Buy	+2,295	New	+$223K	0.02%	247
2014 Q3	–	Sell	-2,745	Closed	-$243K	–	259
2014 Q2	$243K	Sell	2,745 -180	-6%	-$14.2K	0.02%	236
2014 Q1	$230K	Sell	2,925 -225	-7%	-$18.7K	0.02%	228
2013 Q4	$238K	Buy	+3,150	New	+$223K	0.02%	220

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Covington Capital Management's IBB Position: Q3 2022 in Review

Covington Capital Management increased its iShares Biotechnology ETF (IBB) stake by 87% in Q3 2022, buying an estimated $83.8K and bringing the position to 1,450 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #377.

Covington Capital Management first reported a position in IBB in Q4 2013 and has held it in 23 quarters since. The position peaked at $282K in Q2 2015. 830 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Covington Capital Management held 1,450 shares of iShares Biotechnology ETF worth $170K as of Q3 2022.
Covington Capital Management bought 675 iShares Biotechnology ETF shares in Q3 2022, an estimated $83.8K.
iShares Biotechnology ETF made up 0.01% of Covington Capital Management's portfolio in Q3 2022, its #377 holding.
Covington Capital Management first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 23 quarters since.
Covington Capital Management's iShares Biotechnology ETF position peaked at $282K in Q2 2015.
830 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.